92 related articles for article (PubMed ID: 23534785)
1. Cost and effectiveness comparison of immediate colposcopy versus human papillomavirus DNA testing in management of atypical squamous cells of undetermined significance in Turkish women.
Kececioglu M; Seckin B; Baser E; Togrul C; Kececioglu TS; Cicek MN; Gungor T
Asian Pac J Cancer Prev; 2013; 14(1):511-4. PubMed ID: 23534785
[TBL] [Abstract][Full Text] [Related]
2. Comparison of human papillomavirus DNA testing and repeat Papanicolaou test in women with low-grade cervical cytologic abnormalities: a randomized trial. HPV Effectiveness in Lowgrade Paps (HELP) Study No. 1 Group.
Lytwyn A; Sellors JW; Mahony JB; Daya D; Chapman W; Ellis N; Roth P; Lorincz AT; Gafni A
CMAJ; 2000 Sep; 163(6):701-7. PubMed ID: 11022584
[TBL] [Abstract][Full Text] [Related]
3. Impact of variations in triage cytology interpretation on human papillomavirus-based cervical screening and implications for screening algorithms.
Ronco G; Zappa M; Franceschi S; Tunesi S; Caprioglio A; Confortini M; Del Mistro A; Carozzi F; Segnan N; Zorzi M; Giorgi-Rossi P;
Eur J Cancer; 2016 Nov; 68():148-155. PubMed ID: 27755998
[TBL] [Abstract][Full Text] [Related]
4. Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in Australia.
Simms KT; Hall M; Smith MA; Lew JB; Hughes S; Yuill S; Hammond I; Saville M; Canfell K
PLoS One; 2017; 12(1):e0163509. PubMed ID: 28095411
[TBL] [Abstract][Full Text] [Related]
5. Risk of cervical high-grade squamous intraepithelial neoplasia in cytologic negative and persistently high-risk human papillomavirus positive patients according to genotypes: a retrospective single center analysis.
Kipp B; Ulrich E; van Meegen C; Schwenzer T
BMC Infect Dis; 2024 Jun; 24(1):558. PubMed ID: 38834951
[TBL] [Abstract][Full Text] [Related]
6. Risk of high-grade precancerous lesions and invasive cancers in high-risk HPV-positive women with normal cervix or CIN 1 at baseline-A population-based cohort study.
Mittal S; Basu P; Muwonge R; Banerjee D; Ghosh I; Sengupta MM; Das P; Dey P; Mandal R; Panda C; Biswas J; Sankaranarayanan R
Int J Cancer; 2017 Apr; 140(8):1850-1859. PubMed ID: 28108997
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of colposcopy after the addition of human papillomavirus testing to the Turkish cervical cancer screening program.
Gunes AC; Ozgul N; Turkyılmaz M; Kara F; Unlu F; Ayhan A; Gultekin M
Cancer Med; 2023 Dec; 12(24):21751-21760. PubMed ID: 37994572
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of high-risk human papillomavirus testing for cervical cancer screening in Québec, Canada.
Vijayaraghavan A; Efrusy MB; Mayrand MH; Santas CC; Goggin P
Can J Public Health; 2010; 101(3):220-5. PubMed ID: 20737813
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of repeated self-sampling for HPV testing in primary cervical screening: a randomized study.
Aarnio R; Östensson E; Olovsson M; Gustavsson I; Gyllensten U
BMC Cancer; 2020 Jul; 20(1):645. PubMed ID: 32660432
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of TruScreen for detecting CIN2+ in women with ThinPrep cytologic test results indicating atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions.
Yang X; He L; Xiao X; Yan L; Shi L; Ren Z; Cai H; Fu C
Future Oncol; 2023 Dec; 19(37):2493-2504. PubMed ID: 38054304
[No Abstract] [Full Text] [Related]
11. The clinical meaning of a cervical intraepithelial neoplasia grade 1 biopsy.
Castle PE; Gage JC; Wheeler CM; Schiffman M
Obstet Gynecol; 2011 Dec; 118(6):1222-1229. PubMed ID: 22105250
[TBL] [Abstract][Full Text] [Related]
12. Cervix cytology samples revealed increased methylation of the human markers FAM19A4/miR124-2 up to 8 years before adenocarcinoma.
Lindroth Y; Pedersen L; Alssamaray J; Berglund T; Sundqvist A; Borgfeldt C; Forslund O
Acta Obstet Gynecol Scand; 2024 Feb; 103(2):378-386. PubMed ID: 37964497
[TBL] [Abstract][Full Text] [Related]
13. Implications of semi-quantitative HPV viral load estimation by Hybrid capture 2 in colposcopy practice.
Basu P; Muwonge R; Mittal S; Banerjee D; Ghosh I; Panda C; Mandal R; Sankaranarayanan R
J Med Screen; 2016 Jun; 23(2):104-10. PubMed ID: 26566949
[TBL] [Abstract][Full Text] [Related]
14. Cervical Cancer Screening and Treatment Algorithms Using Human Papillomavirus Testing-Lessons Learnt from a South African Pilot Randomized Controlled Trial.
Sebitloane HM; Forestier M; Ginindza TG; Dhlomo W; Moodley-Govender E; Darragh TM; Baena A; Herrero R; Almonte M; Broutet N; De Vuyst H
Cancer Epidemiol Biomarkers Prev; 2024 Jun; 33(6):779-787. PubMed ID: 37955560
[TBL] [Abstract][Full Text] [Related]
15. Methylation Levels of CADM1, MAL, and MIR124-2 in Cervical Scrapes for Triage of HIV-Infected, High-Risk HPV-Positive Women in Kenya.
De Vuyst H; Franceschi S; Plummer M; Mugo NR; Sakr SR; Meijer CJ; Heideman DA; Tenet V; Snijders PJ; Hesselink AT; Chung MH
J Acquir Immune Defic Syndr; 2015 Nov; 70(3):311-8. PubMed ID: 26473640
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis of primary human papillomavirus testing in cervical cancer screening: Results from the HPV FOCAL Trial.
Cromwell I; Smith LW; van der Hoek K; Hedden L; Coldman AJ; Cook D; Franco EL; Krajden M; Martin R; Lee MH; Stuart G; van Niekerk D; Ogilvie G; Peacock S
Cancer Med; 2021 May; 10(9):2996-3003. PubMed ID: 33811457
[TBL] [Abstract][Full Text] [Related]
17. Cervical cancer screening coverage, management of squamous intraepithelial lesions and related costs in France.
de Rycke Y; Tubach F; Lafourcade A; Guillo S; Dalichampt M; Dahlab A; Bresse X; Uhart M; Bergeron C; Borne H; Cancalon C; Lajoinie A; Bénard S
PLoS One; 2020; 15(2):e0228660. PubMed ID: 32053648
[TBL] [Abstract][Full Text] [Related]
18. Recommendations for Use of p16/Ki67 Dual Stain for Management of Individuals Testing Positive for Human Papillomavirus.
Clarke MA; Wentzensen N; Perkins RB; Garcia F; Arrindell D; Chelmow D; Cheung LC; Darragh TM; Egemen D; Guido R; Huh W; Locke A; Lorey TS; Nayar R; Risley C; Saslow D; Smith RA; Unger ER; Massad LS;
J Low Genit Tract Dis; 2024 Apr; 28(2):124-130. PubMed ID: 38446575
[TBL] [Abstract][Full Text] [Related]
19. The use of colposcopy for triage in HPV-positive women aged 65 years and older.
Kuenkel E; Jaeger A; Bohlmann I; Bergauer F; Kuehler-Obbarius C; Prieske K; Maass-Poppenhusen K; Schmalfeldt B; Woelber L
Arch Gynecol Obstet; 2024 Apr; 309(4):1561-1567. PubMed ID: 38081959
[TBL] [Abstract][Full Text] [Related]
20. Performance of cytology and human papillomavirus testing in relation to the menstrual cycle.
Sherman ME; Carreon JD; Schiffman M
Br J Cancer; 2006 Jun; 94(11):1690-6. PubMed ID: 16670716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
